These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7203924)

  • 1. Activation systems in contrast idiosyncrasy.
    Lasser EC; Hang JH; Hamblin AE; Lyon SG; Howard M
    Invest Radiol; 1980; 15(6 Suppl):S2-5. PubMed ID: 7203924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in complement and coagulation factors in a patient suffering a severe anaphylactoid reaction to injected contrast material: some considerations of pathogenesis.
    Lasser EC; Lang JH; Lyon SG; Hamblin AE
    Invest Radiol; 1980; 15(6 Suppl):S6-12. PubMed ID: 7203950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in the kallikrein-kinin and complement system in angiography using non-ionic contrast media].
    Hoffmeister HM; Fuhrer G; Pirschel J; Heller W
    Klin Wochenschr; 1988 Sep; 66(17):760-3. PubMed ID: 3263537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of suramin on complement, blood clotting, fibrinolysis and kinin formation.
    Eisen V; Loveday C
    Br J Pharmacol; 1973 Dec; 49(4):678-87. PubMed ID: 4788038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiographic contrast media and the coagulation and complement systems.
    Hoffmeister HM; Heller W
    Invest Radiol; 1996 Sep; 31(9):591-5. PubMed ID: 8877497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiocontrast reactions.
    Lieberman P; Siegle RL; Treadwell G
    Clin Rev Allergy; 1986 May; 4(2):229-45. PubMed ID: 2870792
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological effects and the mechanism of complement activation--interaction among complement, coagulation, fibrinolysis and kinin generation system].
    Kondo M; Takemura S
    Nihon Rinsho; 1979 May; 37(5):1038-43. PubMed ID: 381718
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement and coagulation: causative considerations in contrast catastrophies.
    Lasser EC; Slivka J; Lang JH; Kolb WP; Lyon SG; Hamblin AE; Nazareno G
    AJR Am J Roentgenol; 1979 Feb; 132(2):171-6. PubMed ID: 105577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of complement system with coagulation, fibrinolysis, and kinin generation].
    Kondo M
    Rinsho Ketsueki; 1976 Jan; 17(1):1-14. PubMed ID: 135104
    [No Abstract]   [Full Text] [Related]  

  • 11. Clivarin and other LMWHs in an ex vivo cardiopulmonary bypass model. Studies on contact activation.
    Heller W; Wendel HP
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S45-54. PubMed ID: 8180329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
    Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
    J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The "Hageman" connection: interrelationships of blood coagulation, fibrino(geno)lysis, kinin generation, and complement activation.
    Murano G
    Am J Hematol; 1978; 4(4):409-17. PubMed ID: 362910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
    Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
    Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement, coagulation and fibrinolytic parameters in hereditary angioedema (HAE).
    Cullmann W; Kövary PM; Müller N; Dick W
    Clin Exp Immunol; 1982 Sep; 49(3):618-22. PubMed ID: 7172497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prekallikrein activation, C1 esterase inhibitor, and factor XII as predictors of adverse reaction to contrast media. A prospective study.
    Hagan JJ; Yost FJ; Nickoloff EL
    Invest Radiol; 1987 Jun; 22(6):490-4. PubMed ID: 3497903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
    Schreiber AD; Kaplan AP; Austen KF
    J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
    Munkvad S
    Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse reactions produced by iodinated contrast media.
    Tabar AI; Gamboa PM; García-Delgado F; Oehling A
    Allergol Immunopathol (Madr); 1986; 14(1):71-7. PubMed ID: 2421567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.